Ionis Pharmaceuticals IONS Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's increase (decrease) in income taxes payable, net of income taxes receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's increase (decrease) in income taxes payable, net of income taxes receivable?
- Ionis Pharmaceuticals (IONS) reported increase (decrease) in income taxes payable, net of income taxes receivable of $669.75K in Q4 2025.
- How has Ionis Pharmaceuticals's increase (decrease) in income taxes payable, net of income taxes receivable changed year-over-year?
- Ionis Pharmaceuticals's increase (decrease) in income taxes payable, net of income taxes receivable increased by 226.5% year-over-year, from -$529.25K to $669.75K.
- What is the long-term trend for Ionis Pharmaceuticals's increase (decrease) in income taxes payable, net of income taxes receivable?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's increase (decrease) in income taxes payable, net of income taxes receivable has grown at a 75.9% compound annual growth rate (CAGR), from -$280K to $2.68M.